Latest Articles

Publication Date
Risk factors for uterine adenomyosis diagnosed by MRI in women of reproductive age.

Adenomyosis is a condition characterized by the presence of endometrial glands and stroma within the myometrium. It can manifest as either focal or diffuse. While histopathological examination of the uterus …

Published: March 9, 2025, midnight
Lymphedema Risk After Sentinel Node Mapping in Endometrial Cancer - Physician's Weekly

Lymphedema Risk After Sentinel Node Mapping in Endometrial Cancer Physician's Weekly

Published: March 7, 2025, 8:30 a.m.
Stem cell theory: A new horizon for the treatment of endometriosis by targeting mesenchymal stem cell.

Endometriosis is a prevalent chronic gynecological disease that poses significant challenges for treatment due to its extensive lesions, diverse morphology, unknown etiology, and tendency for recurrence. In the early 21st …

Published: March 7, 2025, midnight
Oxidative stress in endometriosis: Sources, mechanisms and therapeutic potential of antioxidants (Review).

Endometriosis affects ~15% of women of reproductive age worldwide, impacting ~190 million individuals. Despite its high prevalence, the precise pathogenesis of endometriosis remains unclear. Emerging evidence has highlighted oxidative stress …

Published: March 7, 2025, midnight
Newly discovered biomarkers could improve endometrial cancer treatment - MSN

Newly discovered biomarkers could improve endometrial cancer treatment MSN

Published: March 6, 2025, 7:35 p.m.
Conference MDAngle: SGO 2025 Endometrial Cancer - Medscape

Conference MDAngle: SGO 2025 Endometrial Cancer Medscape

Published: March 6, 2025, 6:04 p.m.
SGO 2025: Previewing Advancements in Endometrial Cancer - Medscape

SGO 2025: Previewing Advancements in Endometrial Cancer Medscape

Published: March 6, 2025, 5:55 p.m.
Endothelial senescence induced by PAI-1 promotes endometrial fibrosis - Nature.com

Endothelial senescence induced by PAI-1 promotes endometrial fibrosis Nature.com

Published: March 6, 2025, 5:36 p.m.
Immunotherapy Continues to Redefine Treamtent Considerations in Advanced/Recurrent Endometrial Cancer - OncLive

Immunotherapy Continues to Redefine Treamtent Considerations in Advanced/Recurrent Endometrial Cancer OncLive

Published: March 6, 2025, 2:32 p.m.
Establishment and validation of a prognostic nomogram for overall survival in type II endometrial carcinoma patients - Nature.com

Establishment and validation of a prognostic nomogram for overall survival in type II endometrial carcinoma patients Nature.com

Published: March 6, 2025, 6:11 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!